Prestige Consumer Healthcare Inc. (PBH): Gross Profit
$595.58M
Year ended 2026-03-31
$591.43M
Trailing 12 months to 2026-06-30
-1.6%
3-year compound annual growth
+1.7%
5-year compound annual growth
+2.5%
10-year compound annual growth
| Period ended | Gross Profit | Change YoY | Source filing |
|---|---|---|---|
| 2026-03-31 | $595.58M | -6.1% | 2026-05-14, From 2025-04-01 |
| 2025-03-31 | $634.46M | +1.6% | 2026-05-14, From 2024-04-01 |
| 2024-03-31 | $624.45M | -0.1% | 2026-05-14, From 2023-04-01 |
| 2023-03-31 | $625.29M | +0.7% | 2025-05-09, From 2022-04-01 |
| 2022-03-31 | $620.65M | +13.4% | 2024-05-15, From 2021-04-01 |
| 2021-03-31 | $547.47M | -0.9% | 2023-05-05, From 2020-04-01 |
| 2020-03-31 | $552.22M | -0.6% | 2022-05-06, From 2019-04-01 |
| 2019-03-31 | $555.58M | -3.6% | 2021-05-07, From 2018-04-01 |
| 2018-03-31 | $576.50M | +15.2% | 2020-05-08, From 2017-04-01 |
| 2017-03-31 | $500.29M | +7.1% | 2019-05-13, From 2016-04-01 |
| 2016-03-31 | $467.21M | +15.0% | 2018-05-10, From 2015-04-01 |
| 2015-03-31 | $406.22M | +21.1% | 2017-05-17, From 2014-04-01 |
| 2014-03-31 | $335.55M | -2.4% | 2016-05-17, From 2013-04-01 |
| 2013-03-31 | $343.74M | n/c | 2015-05-14, From 2012-04-01 |
| 2012-03-31 | $227.38M | +33.1% | 2014-05-19, From 2011-04-01 |
| 2011-03-31 | $170.88M | +11.4% | 2013-05-17, From 2010-04-01 |
| 2010-03-31 | $153.44M | n/a | 2012-05-18, From 2009-04-01 |
Gross Profit at similar companies
| Company | Year ended | Gross Profit | Change YoY |
|---|---|---|---|
| Prestige Consumer Healthcare Inc. (PBH) | 2026-03-31 | $595.58M | -6.1% |
| Acadia Pharmaceuticals Inc (ACAD) | 2025-12-31 | $982.51M | +12.2% |
| Indivior Pharmaceuticals, Inc. (INDV) | 2025-12-31 | $994.00M | +3.9% |
| Harmony Biosciences Holdings, Inc. (HRMY) | 2025-12-31 | $670.11M | +20.1% |
| Alkermes plc. (ALKS) | 2025-12-31 | $1.28B | -2.5% |
| Phibro Animal Health Corp (PAHC) | 2026-06-30 | $512.51M | +28.1% |
| Collegium Pharmaceutical, Inc (COLL) | 2025-12-31 | $463.26M | +22.8% |
| Emergent BioSolutions Inc. (EBS) | 2025-12-31 | $416.70M | +15.0% |
| Pacira BioSciences, Inc. (PCRX) | 2025-12-31 | $576.66M | +8.7% |
Compare PBH, ACAD, INDV, HRMY side by side · Screen every company in Pharmaceutical Preparations ↗